Enhancing CAD Diagnosis in Intermediate Risk Patients: added value of multimodality imaging
Marco Francone, Milan / Italy
cCTA patient case (patient with intermediate risk and suspected CAD has a cCTA which confirms CAD)
•highlight diagnostic accuracy of cCTA, diagnosing CAD
•showcase seamless workflow: Bayer supports with CME, injectors and WFS software that saves resources and increases image quality for efficient and fast patient diagnosis
•ideally showcase how the Bayer portfolio has made an impact in clinical life to support cCTA as a routine test
•answer final question: How can personalized cardiac CT successfully be established as a clinical routine diagnostic test?